Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...

Sometimes a strain develops that, while not entirely new, is new enough to spread more efficiently because it is not well ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

The regulator backed the medicine after phase 3 data showed dramatic reductions in HAE attacks and sustained disease control ...

Dr S. Shahzad Mustafa highlights new systemic therapies for urticaria, their impact on quality of life, and the need for ways ...

Avian flu in humans may have made a reappearance after 9 months, according to a press release from the Washington State ...

A trial finds a liberal vs restrictive transfusion threshold for at-risk cardiac patients may improve heart failure and ...

An analysis of a German multicentre study reveals that women are more likely than men to receive inappropriate diagnostic ...

Karina Volkova trains in a clinic using a temporary permit that expires in 2027, giving her a narrow window to clear all ...

A new opinion paper shows no convincing evidence that there is a causal link between gut bacteria and autism, citing weak ...

Somatic mutations with effects similar to those seen with VEXAS syndrome are increasingly seen as possible drivers of ...

Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...